Assessment during stepwise exercise
Lowlanders | Highlanders | Between group difference | p-value | |
Subjects | 22 | 52 | ||
SpO2 % | ||||
Baseline | 96±2 | 91±3 | −5 (−6 to −4) | <0.001 |
End-exercise | 95±1 | 89±3 | −6 (−8 to −5) | <0.001 |
End-exercise−baseline | −0.4±1.1 | −1.4±2.9 | −1.0 (−2.2 to 0.3) | 0.133 |
Heart rate beats·min−1 | ||||
Baseline | 77±13 | 82±12 | 5 (−2 to 11) | 0.137 |
End-exercise | 101±15 | 110±14 | 9 (2 to 16) | 0.012 |
End-exercise−baseline | 24±15 | 28±13 | −4 (−2 to 11) | 0.185 |
TRPG mmHg | ||||
Baseline | 13.9±4.2 | 22.8±5.5 | 8.9 (6.3 to 11.5) | <0.001 |
End-exercise | 20.0±7.4 | 36.4±12.2 | 16.4 (10.8 to 21.9) | <0.001 |
End-exercise−baseline | 6.1±4.8 | 13.6±10.5 | 7.5 (2.8 to 12.2) | 0.002 |
Cardiac index L·min·m−2 | ||||
Baseline | 1.98±0.47 | 2.36±0.58 | −0.38 (−0.66 to −0.09) | 0.011 |
End-exercise | 4.00±1.17 | 4.14±0.78 | −0.14 (−0.62 to 0.34) | 0.566 |
End-exercise−baseline | 2.02±0.89 | 1.78±0.61 | 0.24 (−0.13 to 0.61) | 0.206 |
SVI L·min·m−2 | ||||
Baseline | 26.0±5.4 | 29.2±6.8 | −3.3 (−6.6 to 0.1) | 0.055 |
End-exercise | 38.6±6.6 | 37.8±6.3 | 0.8 (−2.5 to 4.1) | 0.634 |
End-exercise−baseline | 12.6±3.7 | 9.3±7.5 | 3.4 (0.0 to 6.8) | 0.052 |
TAPSE cm | ||||
Baseline | 2.1±0.3 | 1.9±0.4 | −0.1 (−0.3 to 0.1) | 0.153 |
End-exercise | 2.7±0.4 | 2.5±0.5 | −0.2 (−0.4 to 0.1) | 0.163 |
End-exercise−baseline | 0.6±0.4 | 0.6±0.4 | 0.0 (−0.2 to 0.2) | 0.739 |
FAC % | ||||
Baseline | 42.7±5.5 | 41.7±8.1 | 1.0 (−6.3 to 4.2) | 0.691 |
End-exercise | 50.0±7.0 | 44.0±7.7 | −6.0 (−11.3 to −0.8) | 0.024 |
End-exercise−baseline | 7.8±7.5 | 3.9±12.0 | −3.9 (−12.7 to 5.0) | 0.380 |
RVEDA cm2 | ||||
Baseline | 13.4±2.2 | 18.1±3.7 | 4.7 (2.4 to 7.1) | <0.001 |
End-exercise | 17.6±2.7 | 19.5±3.4 | 1.8 (−0.4 to 4.1) | 0.112 |
End-exercise−baseline | 3.5±1.8 | 1.8±4.3 | −1.7 (−4.7 to 1.4) | 0.275 |
RVESA cm2 | ||||
Baseline | 7.7±18 | 10.6±2.9 | 2.9 (1.0 to 4.8) | 0.003 |
End-exercise | 8.9±2.5 | 10.9±2.2 | 2.0 (0.4 to 3.6) | 0.014 |
End-exercise−baseline | 0.6±1.3 | 0.2±3.1 | −0.4 (−2.6 to 1.8) | 0.707 |
TAPSE/TRPG mm·mmHg−1 | ||||
Baseline | 1.6±0.5 | 0.9±0.1 | −0.7 (−0.9 to −0.4) | <0.001 |
End-exercise | 1.6±0.8 | 0.8±0.3 | −0.8 (−1.0 to −0.5) | <0.001 |
End-exercise−baseline | −0.1±0.4 | −0.1±0.3 | −0.01 (−0.20 to 0.18) | 0.901 |
TAPSE/sPAP mm·mmHg−1 | ||||
Baseline | 1.1±0.3 | 0.7±0.2 | −0.39 (−0.52 to −0.26) | <0.001 |
End-exercise | 1.2±0.5 | 0.7±0.3 | −0.50 (−0.67 to −0.34) | <0.001 |
End-exercise−baseline | −0.01±0.26 | −0.06±0.23 | −0.04 (−0.17 to 0.09) | 0.515 |
BPs mmHg | ||||
Baseline | 104±19 | 112±15 | 7 (−1 to 15) | 0.094 |
End-exercise | 123±20 | 133±23 | 9 (−2 to 20) | 0.095 |
End-exercise−baseline | 19±12 | 21±17 | 2 (−6 to 10) | 0.579 |
BPd mmHg | ||||
Baseline | 70±11 | 77±10 | 7 (1 to 12) | 0.015 |
End-exercise | 68±14 | 78±13 | 10 (3 to 17) | 0.004 |
End-exercise−baseline | −2±8 | 2±12 | 4 (−2 to 9) | 0.191 |
Data are presented as n, mean±sd or mean difference (95% CI), unless otherwise stated.
Baseline: baseline upright on cycle ergometer; end-exercise: values at end exercise; SpO2: oxygen saturation by pulse oximetry; TRPG: tricuspid regurgitation pressure gradient; SVI: stroke volume index; TAPSE: tricuspid annular plane systolic excursion; FAC: fractional area change; RVEDA: right ventricle end-diastolic area; RVESA: right ventricle end-systolic area; sPAP: systolic pulmonary artery pressure; BPs: blood pressure systolic; BPd: blood pressure diastolic.